Is MGM-15 Legal in Missouri? (2026)

Instrument

statute

Source

https://www.sos.mo.gov/CMSImages/AdRules/moreg/2026/v51n20Oct15/v51n20.pdf

Retrieved

2026-11-02

Fingerprint

6ee81d4d171b6f53

[6.] 7. A temporary listing of substances subject to 
emergency scheduling under federal law shall include any 
material, compound, mixture, or preparation which contains 
any quantity of the following substances:
A. Fentanyl-related substances, their isomers, esters, 
ethers,salts, and salts of isomers,esters, and ethers.	
9850
(I) Fentanyl-related substance means any substance 
not otherwise listed under another Administration Controlled 
Substance Code Number, and for which no exemption or 
approval is in effect under section 505 of the Federal Food, 
Drug, and Cosmetic Act 21 U.S.C. 355, that is structurally related 
to fentanyl by one (1) or more of the following modifications:
(a) Replacement of the phenyl portion of the 
phenethyl group by any monocycle, whether or not further 
substituted in or on the monocycle;
(b) Substitution in or on the phenethyl group with 
alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino, or 
nitro groups; 
(c) Substitution in or on the piperidine ring with 
alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, 
amino, or nitro groups;
(d) Replacement of the aniline ring with any 
aromatic monocycle whether or not further substituted in or 
on the aromatic monocycle; and/or 
(e) Replacement of the N-propionyl group by 
another acyl group.
[B. 4-(2-chlorophenyl)-2-ethyl-9-
methyl-6H-thieno[3,2-f][1,2,4]triazolo
[4,3-a][1,4]diazepine, its salts, isomers, 
and salts of isomers 
(other name: etizolam)	
2780
C. 8-chloro-6-(2-fluorophenyl)-1-
methyl-4H-benzo[f][1,2,4]triazolo
[4,3-a][1,4]diazepine, its salts, 
isomers, and salts of isomers 
(other name: flualprazolam)	
2785
D. 6-(2-chlorophenyl)-1-methyl-8-
nitro-4H-benzo[f][1,2,4]triazolo
[4,3-a][1,4]diazepine, its salts, 
isomers, and salts of isomers 
(other name: clonazolam)	
2786
E. 8-bromo-6-(2-fluorophenyl)-1-
methyl-4H-benzo[f][1,2,4]triazolo
[4,3-a][1,4]diazepine, its salts, 
isomers, and salts of isomers 
(other name: flubromazolam)	
2788
F. 7-chloro-5-(2-chlorophenyl)-1-
methyl-1,3-dihydro-2Hbenzo
[e][1,4]diazepin-2-one, its salts,
isomers, and salts of isomers 
(other name: diclazepam)	
2789
G. Methyl 3,3-dimethyl-2-
(1-(pent-4-en-1-yl)-1H-indazole-
3-carboxamido)butanoate, its 
optical and geometric isomers, 
salts and salts of isomers 
(other name: MDMB–4en–PINACA)	
7090
H. Methyl 2-[[1-(4-fluorobutyl)
indole-3-carbonyl]amino]-3,3-
dimethyl-butanoate, its optical 
and geometric isomers, salts and 
salts of isomers (other names: 
4F–MDMB–BUTICA; 4F–MDMB–BICA)	
7091
I. N-(1-Amino-3,3-dimethyl-1-oxobutan-
2-yl)-1-(pent-4-en-1-yl)-1H-indazole-
3-carboxamide, its optical and 
geometric isomers, salts and salts of 
isomers (other name: ADB–4en–PINACA)	
7092
J. 5-Pentyl-2-(2-phenylpropan-2-yl)pyrido
[4,3-b]indol-1-one, its optical and 
geometric isomers, salts and salts of 
isomers (other names: CUMYL–PEGACLONE;
SGT–151)	
7093
K. Ethyl 2-[[1-(5-fluoropentyl)indole-3-
carbonyl]amino]-3,3-dimethyl-butanoate,
its optical and geometric isomers, salts 
and salts of isomers (other names: 
5F–EDMB–PICA; 5F–EDMB–2201)	
7094
L. Methyl 2-(1-(4-fluorobenzyl)-1H-indole-
3-carboxamido)-3-methyl butanoate, 
its optical and geometric isomers, salts
and salts of isomers (other name: 
MMB–FUBICA)	
7095
M. N-ethyl-2-(2-(4-isopropoxybenzyl)-5-
nitro-1H-benzimidazol-1-yl)ethan-1-amine, 
its isomers, esters, ethers, salts, and salts 
of isomers, esters and ethers (other name: 
N-desethyl isotonitazene)	
9760
N. 2-(4-ethoxybenzyl)-5-nitro-1-(2-
(piperidin-1-yl)ethyl)-1H-benzimidazole, 
its isomers, esters, ethers, salts, and salts
of isomers, esters and ethers (other names:
N-piperidinyl etonitazene; 
etonitazepipne)	
9761
O. 2-(4-methoxybenzyl)-5-nitro-1-(2-
(pyrrolidin-1-yl)ethyl)-1H-benzimidazole,
its isomers, esters, ethers, salts, and salts
of isomers, esters and ethers (other names:
N-pyrrolidino metonitazene; 
metonitazepyne)	
9762
P. 5-nitro-2-(4-propoxybenzyl)-1-(2-
(pyrrolidin-1-yl)ethyl)-1H-benzimidazole, its
isomers, esters, ethers, salts, and salts of 
Emergency Rules
October 15, 2026
Vol. 51, No. 20
Page 1325
isomers, esters and ethers (other names:
N-pyrrolidino protonitazene; 
protonitazepyne)	
9763]
B. 
2-(2-((2,3-dihydrobenzofuran-5-yl)methyl)-5-
nitro-1H-benzimidazol-1-yl)-N, N-diethylethan-1-amine, its 
isomers, esters, ethers, salts, and salts of isomers, esters 
and ethers (Other name: Ethyleneoxynitazene)	
9770
C. 
2-(2-(benzodioxol-5-ylmethyl)-5-nitro-1H-
benzimidazol-1-yl)-N,N-diethylethan-1-amine, 
its 
isomers, esters, ethers, salts, and salts of isomers, esters 
and 
ethers 
(Other 
names: 
Methylenedioxynitazene; 
3′,4′-methylenedioxynitazene)	
9766
D. 2-(2-(4-ethoxybenzyl)-5-methyl-1H-benzimidazol-
1-yl)-N, N-diethylethan-1-amine, its isomers, esters, ethers, 
salts, and salts of isomers, esters and ethers (Other name: 
5-methyl etodesnitazene)	
9767
E. 
2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol1-
yl)-N-ethylethan-1-amine, its isomers, esters, ethers, salts, 
and salts of isomers, esters and ethers (Other name: 
N-desethyl etonitazene)	
9768
F. 
N-ethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-
benzimidazol-1-yl)ethan-1-amine its isomers, esters, ethers, 
salts, and salts of isomers, esters and ethers (Other name: 
N-desethyl protonitazene)	
9769
G. 
2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol1-
yl)-N,N-dimethylethan-1-amine, its isomers, esters, ethers, 
salts, and salts of isomers, esters and ethers (Other name: 
N,N-dimethylamino etonitazene)	
9771
H. 2-(4-isopropoxybenzyl)-5-nitro-1-(2-(pyrrolidine1-
yl)ethyl)-1H-benzimidazole, its isomers, esters, ethers, 
salts, and salts of isomers, esters and ethers (Other name: 
N-pyrrolidino isotonitazene)	
9772
I. 
8-bromo-1-methyl-6-phenyl-4H-benzo[f][1,2,4]
triazolo[4,3-a][l ,4]diazepine, its salts, isomers, and salts of 
isomers (Other names: bromazolam)	
2778
J. 2-Fluorodeschloroketamine, its salts, isomers, 
and salts of isomers (other name: 2-(2-fluorophenyl)2-
(methylamino)cyclohexan-1-one; also known as 2-FDCK)	
	
7284
K. O-Desmethyltramadol (other names: O-DSMT; 
desmetramadol; 
3-[(1R,2R)-2-[(dimethylamino)methyl]-1-
hydroxycyclohexyl]phenol)	
9667
L. 
Methyl 
(E)-2-((1′S,6′S,7′S)-6′-ethyl-4-methoxy-3-
oxo-3′,5′,6′,7′,8′,8a′-hexahydro-2′H-spiro[indoline-2,1′-
indolizine]-7′-yl)-3-methoxyacrylate 
(commonly 
known 
as mitragynine pseudoindoxyl) including its isomers, 
esters, ethers, salts, and salts of isomers, esters, and ethers, 
whenever the existence of such isomers, esters, ethers, 
and salts is possible. Since nomenclature of this substance 
is not internationally standardized, compounds of this 
structure, regardless of numerical designation of atomic 
positions are covered. 	
9672
M. 
Methyl 
(E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-
7a-hydroxy-8-methoxy-1 ,2, 3,4,6 ,7,7a,12,12a,12b 
decahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate 
(commonly known as MGM-15; also known as dihydro-7-
hydroxymitragynine) including its isomers, esters, ethers, 
salts, and salts of isomers, esters, and ethers, whenever 
the existence of such isomers, esters, ethers, and salts 
is possible. Since nomenclature of this substance is not 
internationally standardized, compounds of this structure, 
regardless of numerical designation of atomic positions 
are covered.	
9673
N. 
Methyl 
(E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-9-
fluoro-7a-hydroxy-8- 
methoxy-1,2,3,4,6,7,7a,12,12a,12b-
decahydroindolo[2,3-a]quinolizin-2-yl)-3 methoxyacrylate 
(commonly known as MGM-16; also known as 9-fluoro-
dihydro-7-hydroxymitragynine; 
or 
10-fluoro-dihydro-
7-hydroxymitragynine 
(depending 
on 
numbering 
convention)) including its isomers, esters,ethers, salts, and 
salts of isomers, esters, and ethers, whenever the existence 
of such isomers, esters, ethers, and salts is possible. Since 
nomenclature of this substance is not internationally 
standardized, compounds of this structure, regardless of 
numerical designation of atomic positions are covered.	
	
9674
O. 
1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-
5,6-dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one, 
its 
isomers, esters, ethers, salts, and salts of isomers, esters, 
and ethers (Other names: 5,6-dichloro brorphine; SR-
14968) 	
9097
P. 
5,6-dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-
1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, 
ethers, salts, and salts of isomers, esters, and ethers (Other 
names: 5,6-dichloro desmethylchlorphine; SR-17018) 	9096
Q. 
3-(3-(1-(1-(4-chlorophenyl)ethyl)piperidin-4-yl)-2-
oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)propanenitrile, 
its isomers, esters, ethers, salts, and salts of isomers, esters, 
and ethers (Other names: N-propionitrile chlorphine; 
cychlorphine) 	
9094
R. 
8-(1-(4-chlorophenyl)ethyl)-1-phenyl-
1,3,8triazaspiro[4.5]decan-4-one, 
its 
isomers, 
esters, 
ethers,salts, and salts of isomers, esters, and ethers (Other 
names: spirochlorphine; R-6890) 	
9093

Instrument

Executive Order 24-10 -- directing DHSS to designate foods containing unregulated psychoactive cannabis products as coming from an unapproved food source / containing an unapproved food additive, and to embargo and condemn such foods; directing Division of Alcohol and Tobacco Control to prohibit sale on liquor-licensed premises

Source

https://www.sos.mo.gov/library/reference/orders/2024/eo10

Retrieved

2026-07-02

Fingerprint

40421b2949322e51

EXECUTIVE ORDER 24-10

WHEREAS, there are currently no safety standards, packaging requirements, or other regulations related to the safety of consuming unregulated psychoactive cannabis products in Missouri; and

WHEREAS, unregulated psychoactive cannabis products include delta-8 tetrahydrocannabinol (THC), delta-10 THC, hexahydrocannabinol (HHC), tetrahydrocannabinol (THC-O), tetrahydrocannabiphoral (THCP), tetrahydrocannabivarin (THCV), and other similar compounds; and

WHEREAS, numerous Missourians have been negatively impacted by the consumption of foods with unregulated psychoactive cannabis products added to them; and

WHEREAS, Missouri children, and children across the nation, have been hospitalized due to consuming unregulated psychoactive cannabis products; and

WHEREAS, additional actions must be taken to protect consumers, including children, from the sale of foods that include unregulated psychoactive cannabis products; and

WHEREAS, the Missouri Department of Health and Senior Services (DHSS) is tasked with ensuring the protection of the public when it comes to food under Chapter 196, RSMo; and

WHEREAS, the DHSS is tasked with promulgating regulations that conform, insofar as practicable, with those promulgated under federal acts under Section 196.045, RSMo; and

WHEREAS, state law currently prohibits the sale of foods that are adulterated or misbranded under Section 196.015, RSMo; and

WHEREAS, the DHSS has promulgated rules and a Food Code under Section 196.045, RSMo, which align with the United States Food and Drug Administration (FDA); and

WHEREAS, the FDA and the Missouri Food Code require that all food come from approved sources; and

WHEREAS, the FDA and the Missouri Food Code require that food that is not from an approved source shall be discarded; and

WHEREAS, the FDA and the Missouri Food Code require that food additives must be approved food additives or come from approved food sources; and

WHEREAS, there is no unregulated psychoactive cannabis product that has been approved by the FDA as a food additive; and

WHEREAS, the FDA has stated that food additives must receive premarket approval, and the failure to obtain premarket approval causes the food to be marked as adulterated by the FDA; and

WHEREAS, Section 311.660, RSMo, provides the Missouri Division of Alcohol and Tobacco Control within the Missouri Department of Public Safety with the statutory authority to enforce Missouri's alcohol and tobacco laws and regulations to ensure a safe environment for citizens of Missouri; and

WHEREAS, Missouri regulations currently prohibit the sale of controlled substances on liquor-licensed premises, but are silent on the sale of other unregulated psychoactive cannabis products.

NOW, THEREFORE, I, MICHAEL L. PARSON, GOVERNOR OF THE STATE OF MISSOURI, by virtue and authority vested in me by the Constitution and laws of the State of Missouri, do hereby order the DHSS, beginning on September 1, 2024, to designate foods containing unregulated psychoactive cannabis products as foods that come from an unapproved food source or as foods that contain an unapproved food additive that comes from an unapproved food source as set forth in the 2022 FDA Food Code and the 2013 Missouri Food Code, or revisions of said codes. Additionally, the DHSS is to find foods that contain unregulated psychoactive cannabis products are deleterious, poisonous, and adulterated under Sections 196.070, RSMo, and 196.085, RSMo, and to take the necessary steps in accordance with statute and regulation to embargo and condemn any food containing unregulated psychoactive cannabis products. These provisions do not apply to products under the control or purview of the Division of Cannabis Regulation under Article XIV of the Missouri Constitution as long as all psychoactive cannabinoids in those products are sourced from establishments licensed under Article XIV of the Missouri Constitution.

I further direct the DHSS to produce and distribute information regarding how the DHSS will regulate products consistent with this Executive Order.

I further direct the Missouri Division of Alcohol and Tobacco Control to amend its regulations such that unregulated psychoactive cannabis products are prohibited from being sold on the premises of a liquor-licensed facility.

IN WITNESS WHEREOF, I have hereunto set my hand and caused to be affixed the Great Seal of the State of Missouri, in the City of Jefferson, on this 1st day of August, 2024.

MICHAEL L. PARSON, GOVERNOR

ATTEST: JOHN R. ASHCROFT, SECRETARY OF STATE

Instrument

Schedule I

Source

https://revisor.mo.gov/main/OneSection.aspx?section=195.017

Retrieved

2026-10-29

Fingerprint

59beff39e9948e8d

2.  Schedule I:

  (1)  The controlled substances listed in this subsection are included in Schedule I;

  (2)  Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation:

  (a)  Acetyl-alpha-methylfentanyl (N-(1-(1-methyl-2-phenethyl)-4-piperidinyl)-N-phenylacetamide);

  (b)  Acetylmethadol;

  (c)  Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);

  (d)  Acryl fentanyl (-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide);

  (e)  AH-7921(3,4-dichloro-N-
[
(1-dimethylamino) cyclohexylmethyl
]
 benzamide);

  (f)  Allylprodine;

  (g)  Alphacetylmethadol (except levoalphacetylmethadol, also known as levo-alpha-acetylmethadol levothadyl acetate or LAAM);

  (h)  Alphameprodine;

  (i)  Alphamethadol;

  (j)  Alpha-methylfentanyl (N-1-(alphamethyl-beta-phenyl) ethyl-4-piperidyl) propionanilide; 1-(1-methyl-2-phenylethyl)-4 ((N-propanilido) piperidine);

  (k)  Alpha-methylthiofentanyl (N-(1-methyl-2-(2-thienyl) ethyl-4-piperidinyl)-N-phenylpropanamide);

  (l)  Benzethidine;

  (m)  Betacetylmethadol;

  (n)  Beta-hydroxyfentanyl (N-(1-(2-hydroxy-2-phenethyl)-4-piperidinyl)-N-phenylpropanamide);

  (o)  Beta-hydroxy-3-methylfentanyl (N-(1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl)-N-phenylpropanamide);

  (p)  Betameprodine;

  (q)  Betamethadol;

  (r)  Betaprodine;

  (s)  Clonitazene;

  (t)  Dextromoramide;

  (u)  Diampromide;

  (v)  Cyclopropyl fentanyl;

  (w)  Diethylthiambutene;

  (x)  Difenoxin;

  (y)  Dimenoxadol;

  (z)  Dimepheptanol;

  (aa)  Dimethylthiambutene;

  (bb)  Dioxaphetyl butyrate;

  (cc)  Dipipanone;

  (dd)  Ethylmethylthiambutene;

  (ee)  Etonitazene;

  (ff)  Etoxeridine;

  (gg)  4-fluoroisobutyryl fentanyl -(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide;

  (hh)  Furanyl fentanyl -(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide;

  (ii)  Furethidine;

  (jj)  Hydroxypethidine;

  (kk)  Ketobemidone;

  (ll)  Levomoramide;

  (mm)  Levophenacylmorphan;

  (nn)  3-Methylfentanyl (N-(3-methyl-1-(2-phenylethyl)-4-piperidyl)-N-phenylproanamide), its optical and geometric isomers, salts, and salts of isomers;

  (oo)  3-Methylthiofentanyl (N-((3-methyl-1-(2-thienyl)ethyl-4-piperidinyl)-N-phenylpropanamide);

  (pp)  Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);

  (qq)  Morpheridine;

  (rr)  MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);

  (ss)  MT-45(1-cyclohexyl-4-(1,2-diphenylethyl) piperazine);

  (tt)  Noracymethadol;

  (uu)  Norlevorphanol;

  (vv)  Normethadone;

  (ww)  Norpipanone;

  (xx)  Ocfentanil N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide;

  (yy)  Ortho-fluorofentanyl (N-2-(1-phenethylpiperidin-yl)propionamide); other name 2-fluorofentanyl;

  (zz)  para-fluorobutyryl fentanyl (N-4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide;

  (aaa)  Para-fluorofentanyl (N-(4-fluorophenyl)-N-(1-(2-phenethyl)-4-piperidinyl)
propanamide
;

  (bbb)  PEPAP (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine);

  (ccc)  Phenadoxone;

  (ddd)  Phenampromide;

  (eee)  Phenomorphan;

  (fff)  Phenoperidine;

  (ggg)  Piritramide;

  (hhh)  Proheptazine;

  (iii)  Properidine;

  (jjj)  Propiram;

  (kkk)  Racemoramide;

  (lll)  Tetrahydrofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide);

  (mmm)  Thiofentanyl (-phenyl-N-(1-(2-thienyl)ethyl-4-piperidinyl)-
propanamide
;

  (nnn)  Tilidine;

  (ooo)  Trimeperidine;

  (3)  Any of the following opium derivatives, their salts, isomers and salts of isomers unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:

  (a)  Acetorphine;

  (b)  Acetyldihydrocodeine;

  (c)  Benzylmorphine;

  (d)  Codeine methylbromide;

  (e)  Codeine-N-Oxide;

  (f)  Cyprenorphine;

  (g)  Desomorphine;

  (h)  Dihydromorphine;

  (i)  Drotebanol;

  (j)  Etorphine (except hydrochloride salt);

  (k)  Heroin;

  (l)  Hydromorphinol;

  (m)  Methyldesorphine;

  (n)  Methyldihydromorphine;

  (o)  Morphine methylbromide;

  (p)  Morphine methylsulfonate;

  (q)  Morphine-N-Oxide;

  (r)  Myrophine;

  (s)  Nicocodeine;

  (t)  Nicomorphine;

  (u)  Normorphine;

  (v)  Pholcodine;

  (w)  Thebacon;

  (4)  Any of the following opiate similar synthetic substances scheduled by the U.S. Drug Enforcement Administration as substances that share a pharmacological profile similar to fentanyl, morphine, and other synthetic opioids, unless specifically excepted or unless listed in another schedule:

  (a)  Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide);

  (b)  U-47700 (3,4-Dichloro-N-
[
2-(dimethylamino) cyclohexyl
]
--methyl benzamide).

  (5)  Any material, compound, mixture or preparation which contains any quantity of the following hallucinogenic substances, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:

  (a)  Alpha-ethyltryptamine;

  (b)  4-bromo-2,5-dimethoxyamphetamine;

  (c)  4-bromo-2,5-dimethoxyphenethylamine;

  (d)  2,5-dimethoxyamphetamine;

  (e)  2,5-dimethoxy-4-ethylamphetamine;

  (f)  2,5-dimethoxy-4-(n)-propylthiophenethylamine;

  (g)  2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine;

  (h)  2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine;

  (i)  2-(2,5-Dimethoxy-4-methylphenyl) ethanamine;

  (j)  2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine;

  (k)  2-(2,5-Dimethoxyphenyl) ethanamine;

  (l)  2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine;

  (m)  2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine;

  (n)  2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine;

  (o)  2-(4-
Isopropylthio
)-2,5-dimethoxyphenyl) ethanamine;

  (p)  4-methoxyamphetamine;

  (q)  5-methoxy-3,4-methylenedioxyamphetamine;

  (r)  4-methyl-2, 5-dimethoxyamphetamine;

  (s)  3,4-methylenedioxyamphetamine;

  (t)  3,4-methylenedioxymethamphetamine;

  (u)  3,4-methylenedioxy-N-ethylamphetamine;

  (v)  N-hydroxy-3, 4-methylenedioxyamphetamine;

  (w)  3,4,5-trimethoxyamphetamine;

  (x)  5-MeO-DMT or 5-methoxy-N,N-dimethyltryptamine;

  (y)  Alpha-methyltryptamine;

  (z)  Bufotenine;

  (aa)  Diethyltryptamine;

  (bb)  Dimethyltryptamine;

  (cc)  5-methoxy-N,N-diisopropyltryptamine;

  (dd)  Ibogaine;

  (ee)  Lysergic acid diethylamide;

  (ff)  Marijuana or marihuana, except industrial hemp;

  (gg)  Mescaline;

  (hh)  Parahexyl;

  (ii)  Peyote, to include all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salt, derivative, mixture or preparation of the plant, its seed or extracts;

  (jj)  N-ethyl-3-piperidyl benzilate;

  (kk)  N-methyl-3-piperidyl benzilate;

  (ll)  Psilocybin;

  (mm)  Psilocyn;

  (nn)  Tetrahydrocannabinols naturally contained in a plant of the genus Cannabis (cannabis plant), except industrial hemp, as well as synthetic equivalents of the substances contained in the cannabis plant, or in the resinous extractives of such plant, or synthetic substances, derivatives and their isomers, or both, with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following:

  a.  1 cis or trans tetrahydrocannabinol and their optical isomers;

  b.  6 cis or trans tetrahydrocannabinol and their optical isomers;

  c.  3,4 cis or trans tetrahydrocannabinol and their optical isomers;

  d.  Any compounds of these structures, regardless of numerical designation of atomic positions covered;

  (oo)  Ethylamine analog of phencyclidine;

  (pp)  Pyrrolidine analog of phencyclidine;

  (qq)  Thiophene analog of phencyclidine;

  (rr)  1-
[
1-(2-thienyl)cyclohexyl
]
pyrrolidine;

  (ss)  Salvia divinorum;

  (tt)  Salvinorin A;

  (uu)  Synthetic cannabinoids:

  a.  Any compound structurally derived from 3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the naphthyl ring to any extent.  Including, but not limited to:

  (i)  AM2201, or 1-(5-fluoropentyl)-3-(1-naphthoyl)indole;

  (ii)  JWH-007, or 1-pentyl-2-methyl-3-(1-naphthoyl)indole;

  (iii)  JWH-015, or 1-propyl-2-methyl-3-(1-naphthoyl)indole;

  (iv)  JWH-018, or 1-pentyl-3-(1-naphthoyl)indole;

  (v)  JWH-019, or 1-hexyl-3-(1-naphthoyl)indole;

  (vi)  JWH-073, or 1-butyl-3-(1-naphthoyl)indole;

  (vii)  JWH-081, or 1-pentyl-3-(4-methoxy-1-naphthoyl)indole;

  (viii)  JWH-098, or 1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole;

  (ix)  JWH-122, or 1-pentyl-3-(4-methyl-1-naphthoyl)indole;

  (x)  JWH-164, or 1-pentyl-3-(7-methoxy-1-naphthoyl)indole;

  (xi)  JWH-200, or 1-(2-(4-(morpholinyl)ethyl))-3-(1-naphthoyl)indole;

  (xii)  JWH-210, or 1-pentyl-3-(4-ethyl-1-naphthoyl)indole;

  (xiii)  JWH-398, or 1-pentyl-3-(4-chloro-1-naphthoyl)indole;

  b.  Any compound structurally derived from 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted in the naphthyl ring to any extent;

  c.  Any compound structurally derived from 1-(1-naphthylmethyl)indene by substitution at the 3-position of the indene ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring to any extent;

  d.  Any compound structurally derived from 3-phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent.  Including, but not limited to:

  (i)  JWH-201, or 1-pentyl-3-(4-methoxyphenylacetyl)indole;

  (ii)  JWH-203, or 1-pentyl-3-(2-chlorophenylacetyl)indole;

  (iii)  JWH-250, or 1-pentyl-3-(2-methoxyphenylacetyl)indole;

  (iv)  JWH-251, or 1-pentyl-3-(2-methylphenylacetyl)indole;

  (v)  RCS-8, or 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole;

  e.  Any compound structurally derived from 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of the phenolic ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent.  Including, but not limited to CP 47, 497 and homologues, or 2-
[
(1R,3S)-3-hydroxycyclohexyl
]
-5-(2-methyloctan-2-yl)phenol, where side chain n=5, and homologues where side chain n-4,6, or 7;

  f.  Any compound containing a 3-(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent.  Including, but not limited to:

  (i)  AM-694, or 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole;

  (ii)  RCS-4, or 1-pentyl-3-(4-methoxybenzoyl)indole (SR-19 and RCS-4);

  g.  CP 50,556-1, or
[
(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-
[
(2R)-5-phenylpentan-2-yl
]
 oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl
]
 acetate;

  h.  HU-210, or (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo
[
c
]
chromen-1-ol;

  i.  HU-211, or Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo
[
c
]
chromen-1-ol;

  j.  Dimethylheptylpyran, or DMHP;

  (6)  Any material, compound, mixture or preparation containing any quantity of the following substances having a depressant effect on the central nervous system, including their salts, isomers and salts of isomers whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:

  (a)  Gamma-hydroxybutyric acid;

  (b)  Mecloqualone;

  (c)  Methaqualone;

  (7)  Any material, compound, mixture or preparation containing any quantity of the following substances having a stimulant effect on the central nervous system, including their salts, isomers and salts of isomers:

  (a)  Aminorex;

  (b)  N-benzylpiperazine;

  (c)  Cathinone;

  (d)  Fenethylline;

  (e)  3-Fluoromethcathinone;

  (f)  4-Fluoromethcathinone;

  (g)  Mephedrone, or 4-methylmethcathinone;

  (h)  Methcathinone;

  (i)  4-methoxymethcathinone;

  (j)  (+,-)cis-4-methylaminorex ((+,-)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);

  (k)  Methylenedioxypyrovalerone, MDPV, or 1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-pentanone;

  (l)  Methylone, or 3,4-Methylenedioxymethcathinone;

  (m)  4-Methyl-alpha-pyrrolidinobutiophenone, or MPBP;

  (n)  N-ethylamphetamine;

  (o)  N,N-dimethylamphetamine;

  (p)  Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (PB-22; QUPIC);

  (q)  Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-fluoro-PB-22; 5F-PB-22);

  (r)  N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA);

  (s)  N-(1-amino-3, 3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADB-PINACA);

  (8)  A temporary listing of substances subject to emergency scheduling under federal law shall include any material, compound, mixture or preparation which contains any quantity of the following substances:

  (a)  (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (b)  
[
1-(5-fluoro-pentyl)-1H-indol-3-yl
]
(2,2,3,3-tetramethylcyclopropyl)methanone, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (c)  N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (d)  2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (e)  2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (f)  2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (g)  4-methyl-N-ethylcathinone, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (h)  4-methyl-alpha-pyrrolidinopropiophenone, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (i)  Alpha-pyrrolidinopentiophenone, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (j)  Butylone, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (k)  Pentedrone, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (l)  Pentylone, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (m)  Naphyrone, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (n)  Alpha-pyrrolidinobutiophenone, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (o)  N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (p)  N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (q)  
[
1-(5-fluoropentyl)-1H-indazole-3-yl
]
(naphthalen-1-yl)methanone, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (r)  N-
[
1-
[
2-hydroxy-2-(thiophen-2-yl) ethyl
]
piperidin-4-yl
]
-N-phenylpropionamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers;

  (s)  N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (t)  N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (u)  methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (v)  methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (w)  N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (x)  N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (y)  methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (z)  methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (aa)  N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers;

  (bb)  methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, its optical, positional, and geometric isomers, salts, and salts of isomers;

  (cc)  N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers;

  (dd)  N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers;

  (ee)  N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers;

  (ff)  N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers;

  (gg)  N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers;

  (hh)  N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers;

  (ii)  N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers;

  (jj)  Fentanyl-related substances, their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers.  Fentanyl-related substance shall mean any substance not otherwise listed under another Drug Enforcement Administration Controlled Substance Code Number, and for which no exemption or approval is in effect under section 505 of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. Section 355, that is structurally related to fentanyl by one or more of the following modifications:

  a.  Replacement of the phenyl portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle;

  b.  Substitution in or on the phenethyl group with alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino or nitro groups;

  c.  Substitution in or on the piperidine ring with alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, amino or nitro groups;

  d.  Replacement of the aniline ring with any aromatic monocycle, whether or not further substituted in or on the aromatic monocycle; or

  e.  Replacement of the N-propionyl group by another acyl group;

  (kk)  Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate, its optical, positional, and geometric isomers, salts, and salts of isomers (NM2201; CBL2201);

  (ll)  N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (5F-AB-PINACA);

  (mm)  1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYLBINACA; CUMYL-4CN-BINACA; SGT-78);

  (nn)  methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate, its optical, positional, and geometric isomers, salts, and salts of isomers (MMB-CHMICA, AMB-CHMICA);

  (oo)  1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo
[
2,3-b
]
pyridine-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (5F-CUMYL-P7AICA);

  (pp)  N-ethylpentylone, its optical, positional, and geometric isomers, salts, and salts of isomers (ephylone, 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-
one
;

  (qq)  ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, its optical, positional, and geometric isomers, salts, and salts of isomers (trivial name: 5F-EDMB-PINACA);

  (rr)  methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate, its optical, positional, and geometric isomers, salts, and salts of isomers (trivial name: 5F-MDMB-PICA);

  (ss)  N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (trivial names: FUB-AKB48; FUB-APINACA; AKB48 N-(4-FLUOROBENZYL));

  (tt)  1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (trivial names: 5F-CUMYL-PINACA; SGT-25);

  (uu)  (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone, its optical, positional, and geometric isomers, salts, and salts of isomers (trivial name: FUB-144);

  (vv)  N-ethylhexedrone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other name: 2-(ethylamino)-1-phenylhexan-1-one);

  (ww)  alpha-pyrrolidinohexanophenone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: α-PHP; alpha-pyrrolidinohexiophenone; 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one);

  (xx)  4-methyl-alpha-ethylaminopentiophenone, its optical, positional, and geometric isomers, salts, and salts of isomers; (Other names: 4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one);

  (yy)  4'-methyl-alpha-pyrrolidinohexiophenone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: MPHP; 4'-methyl-alpha-pyrrolidinohexanophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one);

  (zz)  alpha-pyrrolidinoheptaphenone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: PV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one);

  (aaa)  4'-chloro-alpha-pyrrolidinovalerophenone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: 4-chloro-α-PVP; 4'-chloro-alpha-pyrrolidinopentiophenone; 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one);

  (9)  Khat, to include all parts of the plant presently classified botanically as catha edulis, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seed or extracts.

Instrument

Food, when deemed adulterated

Source

https://revisor.mo.gov/main/OneSection.aspx?section=196.070

Retrieved

2026-10-28

Fingerprint

283c573d5b0dbd0b

1.  A food shall be deemed to be adulterated:

  (1)  If it bears or contains any poisonous or deleterious substance which may render it injurious to health; but in case the substance is not an added substance such food shall not be considered adulterated under this subdivision if the quantity of such substance in such food does not ordinarily render it injurious to health; or

  (2)  If it bears or contains any added poisonous or added deleterious substance which is unsafe within the meaning of section
196.085
; or

  (3)  If it consists, in whole or in part, of any diseased, contaminated, filthy, putrid, or decomposed substance, or if it is otherwise unfit for food; or

  (4)  If it has been produced, prepared, packed, or held under insanitary conditions whereby it may have become contaminated with filth or whereby it may have been rendered diseased, unwholesome, or injurious to health; or

  (5)  If it is, in whole or in part, the product of a diseased animal or of an animal which has died otherwise than by slaughter, or that has been fed upon the uncooked offal from a slaughterhouse; or

  (6)  If its container is composed, in whole or in part, of any poisonous or deleterious substance which may render the contents injurious to health; or

  (7)  If any valuable constituent has been in whole or in part omitted or abstracted therefrom; or

  (8)  If any substance has been substituted wholly or in part therefor; or

  (9)  If damage or inferiority has been concealed in any manner; or

  (10)  If any substance has been added thereto or mixed or packed therewith so as to increase its bulk or weight, or reduce its quality or strength or make it appear better or of greater value than it is; or

  (11)  If it is confectionery and it bears or contains any alcohol or nonnutritive article or substance except harmless coloring, harmless flavoring, harmless resinous glaze not in excess of four-tenths of one percent, harmless natural wax not in excess of four-tenths of one percent, harmless natural gum, and pectin; provided, that this subdivision shall not apply to any confectionery, by reason of its containing less than five percent by weight of alcohol, or to any chewing gum by reason of its containing harmless nonnutritive masticatory substances; or

  (12)  If it bears or contains a coal tar color other than one from a batch which has been certified under authority of the federal act.

  2.  A food shall not be considered adulterated solely for containing industrial hemp, or an industrial hemp commodity or product.